These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21240382)

  • 21. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis.
    Boone J; van Hillegersberg R; Offerhaus GJ; van Diest PJ; Borel Rinkes IH; Ten Kate FJ
    Dis Esophagus; 2009; 22(6):496-504. PubMed ID: 19302210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
    Wang Z; He M; Xiao Z; Wu H; Wu Y
    PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population.
    Howard EM; Lau SK; Lyles RH; Birdsong GG; Tadros TS; Umbreit JN; Kochhar R
    Int J Clin Oncol; 2004 Jun; 9(3):154-60. PubMed ID: 15221598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma.
    Park YB; Kim HS; Oh JH; Lee SH
    Int Orthop; 2001; 24(6):307-10. PubMed ID: 11294418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
    Wu J; Guo A; Li Q; Wang D
    Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
    Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
    J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic significance of p53, HER-2/neu, Ki-67 and VEGF expression in chondrosarcomas].
    Stepanova EV; Kharatishvili TK; Lichinitser MR; Baryshnikov AIu; Solov'ev IuN; Trapeznikov NN
    Arkh Patol; 2002; 64(6):9-12. PubMed ID: 12534219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma.
    Benassi MS; Molendini L; Gamberi G; Magagnoli G; Ragazzini P; Gobbi GA; Sangiorgi L; Pazzaglia L; Asp J; Brantsing C; Picci P
    Cancer; 2001 Dec; 92(12):3062-7. PubMed ID: 11753985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma.
    Li YG; Geng X
    Eur J Cancer Care (Engl); 2010 May; 19(3):313-6. PubMed ID: 19709164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor expression in osteosarcoma.
    Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
    Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic Role of Ezrin and HER2/neu Expression in Osteosarcoma.
    Abdou AG; Kandil M; Asaad NY; Dawoud MM; Shahin AA; Abd Eldayem AF
    Appl Immunohistochem Mol Morphol; 2016; 24(5):355-63. PubMed ID: 26067138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.
    Köstler WJ; Brodowicz T; Hudelist G; Rudas M; Horvat R; Steger GG; Singer CF; Attems J; Rabitsch W; Fakhrai N; Elandt K; Wiltschke C; Hejna M; Zielinski CC
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):420-8. PubMed ID: 15864644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
    Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
    Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and significance of TGF-beta isoform and VEGF in osteosarcoma.
    Jung ST; Moon ES; Seo HY; Kim JS; Kim GJ; Kim YK
    Orthopedics; 2005 Aug; 28(8):755-60. PubMed ID: 16119739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.